Martin C Tammemagi researcher
Tammemagi, Martin Carl, 1948-
VIAF ID: 105683934 (Personal)
Permalink: http://viaf.org/viaf/105683934
Preferred Forms
4xx's: Alternate Name Forms (1)
Works
Title | Sources |
---|---|
Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials. | |
Computer Vision Tool and Technician as First Reader of Lung Cancer Screening CT Scans | |
The Cost-Effectiveness of High-Risk Lung Cancer Screening and Drivers of Program Efficiency. | |
Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts | |
Expert opinion: United States Preventive Services Task Force recommendation on screening for lung cancer. | |
Identification of 14-3-3 theta as an antigen that induces a humoral response in lung cancer | |
Impact of lung cancer screening results on smoking cessation | |
Incremental Value of Pulmonary Function and Sputum DNA Image Cytometry in Lung Cancer Risk Prediction | |
Individualized prediction of lung-function decline in chronic obstructive pulmonary disease. | |
Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate | |
Interval lung cancers not detected on screening chest X-rays: How are they different? | |
Long-term outcomes among African-American and white women with breast cancer: what is the impact of comorbidity? | |
Long-term prognostic role of functional limitations among women with breast cancer | |
Low Prevalence of High-Grade Lesions Detected With Autofluorescence Bronchoscopy in the Setting of Lung Cancer Screening in the Pan-Canadian Lung Cancer Screening Study | |
Lung carcinoma symptoms?An independent predictor of survival and an important mediator of African-American disparity in survival | |
Predictors of adverse smoking outcomes in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial | |
Pro-surfactant protein B as a biomarker for lung cancer prediction. | |
Probability of cancer in pulmonary nodules detected on first screening CT. | |
Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study | |
Risk Stratification for Second Primary Lung Cancer | |
Screening for lung cancer using low dose computed tomography | |
Secondhand Smoke as a Potential Cause of Chronic Rhinosinusitis | |
Smoking and lung cancer survival: the role of comorbidity and treatment. | |
Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review | |
Soluble Mesothelin-Related Peptide and Osteopontin As Markers of Response in Malignant Mesothelioma | |
A study of agreement statistics for lyme disease serology. | |
Targeting of low-dose CT screening according to the risk of lung-cancer death | |
Tobacco smoking, p53 tumour suppressor gene alterations, and clinicopathologic features and prognosis in non-small cell lung cancer. | |
Tobacco use and motivation to stop smoking among long-term smokers who are ineligible for lung cancer screening. | |
The utility of nodule volume in the context of malignancy prediction for small pulmonary nodules |